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Healthcare professionals’ perspectives on access to specialist palliative care 




Background: Fibrotic interstitial lung disease is an incurable disease with poor prognosis. We 
aimed to understand factors affecting decisions regarding referrals to specialist palliative care 
services and to address barriers and facilitators to referrals from healthcare professionals’ 
perspectives.  
Methods: A survey study of healthcare professionals, including respiratory physicians, 
interstitial lung disease nurse specialists, respiratory nurse specialists and palliative care 
physicians, was conducted using a questionnaire, entailing 17 questions. 
Results: Thirty-six respondents, including 15 interstitial lung disease nurse specialists completed 
the questionnaire. Symptom control, psychological/spiritual support, general deterioration and 
end-of-life care were the most common reasons for referrals to specialist palliative care 
services. Most respondents felt confident in addressing palliative care needs and discussing 
palliative care with patients. A few participants emphasised that experienced respiratory nurse 
specialists are well placed to provide symptom management and to ensure continuity of patient 
care. Participants reported that access to palliative care could be improved by increasing 
collaborative work between respiratory and palliative care teams.  
   
 
   
 
 
Conclusions: Most respondents felt that enhancing access to specialist palliative care services 
would benefit patients. However, palliative care and respiratory care should not be considered 
as mutually exclusive and multidisciplinary approach is recommended.    
  
   
 




Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease that causes 5000 deaths each 
year in the UK 1, and non-IPF fibrotic interstitial lung disease also carries poor prognosis with no 
effective treatment 2. People with ILD carry a high burden of physical and psychological 
symptoms and supportive measures such as oxygen therapy are the mainstream of treatment 3. 
Palliative care aims to improve the quality of life by preventing and reducing suffering of 
patients and their families through symptom control and supporting the psychological and 
spiritual needs 4. Specialist palliative care is shown to improve patient satisfaction, reduce 
inpatient hospital stays and improve survival in cancer patients 5, and improve quality of life in 
people with non-malignant chronic respiratory diseases 6. There is variation in the palliative 
care services for people with non-malignant respiratory diseases in the United Kingdom 7. Our 
previous systematic review described delay in referrals to specialist palliative care team (SPCT) 
and low referral rate, patients’ fear of talking about the future, uncertainties about prognosis 
and the roles of palliative care were identified as barriers to accessing palliative care services 8. 
Most studies addressing issues surrounding access to palliative care in people with ILD were 
based on retrospective analysis of medical records and only one study included healthcare 
professionals 9.  
By contacting ILD and palliative care professionals, we aimed to understand factors affecting 
decisions regarding SPCT referrals and to address barriers and facilitators to referring patients 
to SPCT from healthcare professionals’ perspectives.  
 
   
 




Study design  
The questionnaire was developed after literature review and in consultation with people with 
ILD and respiratory and palliative care nursing and medical professionals. The questionnaire 
had two parts. The first part relates to access to SPCT and the second part relates to current 
specialist palliative care provision and available services in participants’ practice. All responses 
were anonymous. At the end of the survey, participants had the opportunity to provide free 
text suggestions. The study was approved by the Faculty of Medicine and Health Sciences 
Research Ethics Committee at University of East Anglia (Reference number 201819-016) and 
had Health Research Authority (HRA) approval (IRAS ID 248634).  
Participants  
Participants were identified by the following routes; (1) ILD clinical service leads (2) Members of 
the East Anglia Interstitial Lung Disease Network (3) Members of the ILD-interdisciplinary 
network (4) Local palliative care professionals. Consent was implicit in undertaking completion 
of the questionnaire.  
Data collection and analysis 
The survey was conducted from March 2019 to April 2019. Questionnaires were completed 
electronically on a web-based system: Research Electronic Data Capture (REDcap, Harvard 
College, Boston, USA).  Data were analysed using descriptive statistics using SPSS (v. 25.0). Free 
text comments were analysed using thematic framework analysis.  
   
 




Reason for referrals  
The response rate is estimated to be approximately 15%. Thirty-six respondents completed the 
questionnaire (Specialist ILD respiratory nurses n=15, Specialist respiratory nurses n=8, 
Specialist ILD physician n=5, General respiratory physician n=5, Specialist palliative care 
physician n=3). Most respondents from respiratory team felt confident in discussing palliative 
care (97.0%), making decisions to refer to SPCT (93.9%), addressing palliative care needs 
(81.8%), providing generalised palliative care (87.9%) and understanding in roles of SPCT in 
management of ILD (90.9%). The most common disease triggers for referral were end of life 
care, general deterioration, poorly controlled symptoms and hospital admissions. Only a 
quarter used physiological measures such as forced vital capacity and diffusing capacity for 
carbon monoxide to guide referrals to SPCT. The GAP (Gender, Age, and Physiology) index, a 
validated tool for predicting mortality risk in IPF 10, was rarely used. 
 Most 
common 
     Least 
common 
 Rank 1 Rank 2 Rank 3 Rank 4 Rank 5 Rank 6 Rank 7 
Symptom control  29 (80.6) 2 (5.6) 4 (11.1) 1 (2.8) 0 0 0 
Psychological/spiritual support 1 (2.8) 20 (55.6) 4 (11.1) 4 (11.1) 3 (8.3) 3 (8.3) 1 (2.8) 
To support maintaining activities of daily living 2 (5.6) 7 (19.4) 12 (33.3) 4 (11.1) 8 (22.2) 0 3 (8.3) 
Care in the last days/weeks of life 2 (5.6) 5 (13.9) 9 (25.0) 9 (25.0) 5 (13.9) 5 (13.9) 1 (2.8) 
To support family & bereavement 0 1 (2.8) 4 (11.1) 8 (22.2) 14 (38.9) 7 (19.4) 2 (5.6) 
On patient’s request 1 (2.8) 0 3 (8.3) 7 (19.4) 4 (11.1) 19 (52.8) 2 (5.6) 
Other  1 (2.8) 1 (2.8) 0 2 (5.6) 1 (2.8) 0 6 (30.6) 
Table 1. Reasons for referrals to specialist palliative care team. Respondents were asked to rank, from 
the most to the least common, reasons for referrals to specialist palliative care team from a pre-specified 
list of options. The table shows the results in order of commonality from the top row to the bottom row.  
 
   
 
   
 
 
Barriers to SPCT referrals 
 
Respiratory professionals concerned that transferring care to palliative care team could result in 
patients feeling abandoned by respiratory team and concerned about loss of continuity of care. 
Approximately half (57.5%) of respiratory healthcare professionals felt that SPCT was unlikely to 
add additional benefits to the patient's management. Respiratory specialist nurses perceived 
that ILD team were skilled to support ILD palliative patients with better understanding in 
respiratory support and ILD management. The majority were aware of patients who did not 
wish to see SPCT and reported common negative perceptions concerning terms “palliative 
care” by patients. Limited resources (e.g. long waiting list, limited beds) were considered as 
main barriers to access SPCT.   
Improving access  
 
Eighty percent (n=29) agreed that ensuring access to SPCT would benefit ILD patients.  
Respondents highlighted that joint clinics and training are important methods to improve 
access to specialist palliative care services. A few respondents suggested that ILD nurse 
palliative care training would maintain continuity of care but would require increasing the 
number of ILD nurse specialists. Use of patient-reported outcome measures and a consultation 
guide to identify palliative care needs, automated referral based on pre-defined criteria or SPCT 
attending ILD MDT at diagnosis were not felt to be useful.  
Discussion  
Respiratory healthcare professionals valued continuity of care throughout patients’ journey and 
concerned that transitioning patient care from respiratory care team to SPCT could potentially 
   
 
   
 
 
exert a detrimental impact. A few respondents emphasized that experienced ILD nurse 
specialists are ideal to provide optimal symptom management as they have more experience in 
dealing with respiratory support, and an interdisciplinary approach was a common suggestion 
to improve delivery of palliative care.  
Although, most respondents were confident in assessing palliative care needs, self-reported 
confidence may not relate to clinical performance and competence 11, and generalist palliative 
care may be prone to focus on the physical aspect of symptoms 12. The British Thoracic Society 
(BTS) ILD registry illustrated that 57% of IPF patients’ palliative care needs were assessed 13. 
This suggests that palliative needs assessments are not frequent. The oncology version of the 
End-of-Life Nursing Education Consortium (ELNEC-Oncology) training programme not only 
improved the perceived effectiveness in providing end-of-life care, but also inspired oncology 
nurses to participate in other palliative care activities such as attending further palliative care 
courses 14. An ILD version of a palliative care education programme could be developed and 
implemented to support respiratory teams.   
Expanding the collaboration between palliative and respiratory team via joint clinics and 
training was identified as the most favourable method to improve access to SPCT in our study. 
Indeed, in previous studies of  advanced lung disease, the integrated care have shown to 
improve access to SPCT and breathless management 15, and symptom control guidelines 
developed between SPCT and respiratory team, joint breathlessness clinics and joint workshop 
were described as examples of good practice 16. The positive effect of a respiratory palliative 
care clinic run by a respiratory physician with special interest was illustrated by one 
   
 
   
 
 
respondent. This could be adopted to bridge the gap of limited resources and facilitate efficient 
transition of care from respiratory team to SPCT without leaving patients feel abandoned by 
specialist team.  
Limited resources in palliative care form a barrier to providing specialist palliative care. 
Additionally, there are insufficient specialist nurses to provide generalist palliative care by ILD 
team. National Institute for Health and Care Excellence (NICE) guideline for the diagnosis of 
management of suspected IPF recommends an ILD specialist nurse should be available at all 
stage of the care pathway 17, but the BTS ILD registry reported that only 61% of centres have a 
dedicated ILD nurse specialist, suggesting needs for expanding ILD specialist nurses. Strategic 
plans such as education programme, hospital policy, implementation of palliative care delivery 
model for people with ILD, need to be established to provide high quality care within finite 
resources.  
Strength and limitation  
 
The advantage of this study was it was completely anonymous and therefore we believe the 
answers are genuine and true. We allowed free text to explore the reasons behind the 
quantitative findings. The main limitations were the low response rate and the imbalance of 
different disciplines. We do not know the exact denominator. Although we forwarded the 
questionnaire to the gate keepers of the networks, we do not know how many people were on 
multiple mailing lists nor how many people received the questionnaire from onward mailing. 
The response rate is therefore an estimate. Hence, our findings should not be considered as a 
representation of ILD healthcare professionals’ views.  
   
 
   
 
 
Conclusion and recommendation  
 
Palliative care and respiratory care should not be considered as two separate entities and a 
multidisciplinary approach is recommended.  Maintaining respiratory/ILD nurse specialists as 
the first port of call and training respiratory/ILD team in various aspects palliative care such as 
psychosocial aspects could bring additional benefits to patients by ensuring continuity of care 
and allow early recognition of patients who need SPCT input. Further qualitative evaluation of 
healthcare professionals would allow us to gain better understanding of respiratory 
professionals’ opinions on establishing a structured palliative care framework tailored to people 
with ILD. A larger survey could allow us to examine variation in services across the UK and 
produce more generalizable results. We also recommend further research of people with ILD 
and their carers to understand their preferred mode of palliative care delivery.  
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